|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for AKR1C1 |
Basic gene info. | Gene symbol | AKR1C1 |
Gene name | aldo-keto reductase family 1, member C1 | |
Synonyms | 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB | |
Cytomap | UCSC genome browser: 10p15-p14 | |
Genomic location | chr10 :5005453-5020158 | |
Type of gene | protein-coding | |
RefGenes | NM_001353.5, | |
Ensembl id | ENSG00000266592 | |
Description | 20 alpha-hydroxysteroid dehydrogenase20-alpha-hydroxysteroid dehydrogenasealdo-keto reductase Caldo-keto reductase family 1 member C1chlordecone reductase homolog HAKRCdihydrodiol dehydrogenase 1dihydrodiol dehydrogenase 1/2dihydrodiol dehydrogenas | |
Modification date | 20141207 | |
dbXrefs | MIM : 600449 | |
HGNC : HGNC | ||
HPRD : 07194 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_AKR1C1 | |
BioGPS: 1645 | ||
Gene Expression Atlas: ENSG00000266592 | ||
The Human Protein Atlas: ENSG00000266592 | ||
Pathway | NCI Pathway Interaction Database: AKR1C1 | |
KEGG: AKR1C1 | ||
REACTOME: AKR1C1 | ||
ConsensusPathDB | ||
Pathway Commons: AKR1C1 | ||
Metabolism | MetaCyc: AKR1C1 | |
HUMANCyc: AKR1C1 | ||
Regulation | Ensembl's Regulation: ENSG00000266592 | |
miRBase: chr10 :5,005,453-5,020,158 | ||
TargetScan: NM_001353 | ||
cisRED: ENSG00000266592 | ||
Context | iHOP: AKR1C1 | |
cancer metabolism search in PubMed: AKR1C1 | ||
UCL Cancer Institute: AKR1C1 | ||
Assigned class in ccmGDB | C |
Top |
Phenotypic Information for AKR1C1(metabolism pathway, cancer, disease, phenome) |
![]() | |
Cancer | CGAP: AKR1C1 |
Familial Cancer Database: AKR1C1 |
* This gene is included in those cancer gene databases. |
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
![]() | |
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 |
![]() | |
OMIM | |
Orphanet | |
Disease | KEGG Disease: AKR1C1 |
MedGen: AKR1C1 (Human Medical Genetics with Condition) | |
ClinVar: AKR1C1 | |
Phenotype | MGI: AKR1C1 (International Mouse Phenotyping Consortium) |
PhenomicDB: AKR1C1 |
Mutations for AKR1C1 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
![]() |
- Statistics for Tissue and Mutation type | Top |
![]() |
- For Inter-chromosomal Variations |
* Inter-chromosomal variantions includes 'interchromosomal amplicon to amplicon', 'interchromosomal amplicon to non-amplified dna', 'interchromosomal insertion', 'Interchromosomal unknown type'. |
![]() |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
![]() |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
ovary | AKR1C1 | chr10 | 5017938 | 5017958 | chr10 | 5029196 | 5029216 | |
pancreas | AKR1C1 | chr10 | 5012496 | 5012516 | chr10 | 86375544 | 86375564 | |
pancreas | AKR1C1 | chr10 | 5012526 | 5012546 | CTNNA3 | chr10 | 68885220 | 68885240 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
![]() |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows AKR1C1 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
![]() |
Top |
![]() |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample |   |   |   | 1 |   |   |   |   | 2 |   |   |   |   |   |   |   |   | |||
GAIN (# sample) |   |   |   | 1 |   |   |   |   | 1 |   |   |   |   |   |   |   |   | |||
LOSS (# sample) |   |   |   |   |   |   |   |   | 1 |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
![]() |
|
![]() |
Top |
![]() |
Stat. for Non-Synonymous SNVs (# total SNVs=26) | (# total SNVs=14) |
![]() | ![]() |
(# total SNVs=0) | (# total SNVs=0) |
Top |
![]() |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr10:5010572-5010572 | p.T147T | 5 |
chr10:5008132-5008132 | p.A37A | 3 |
chr10:5008131-5008131 | p.A37D | 2 |
chr10:5014844-5014844 | p.R250Q | 2 |
chr10:5014886-5014886 | p.G264V | 2 |
chr10:5011017-5011017 | p.V151M | 2 |
chr10:5009133-5009133 | p.S89S | 2 |
chr10:5011032-5011032 | p.D156Y | 1 |
chr10:5008105-5008105 | p.? | 1 |
chr10:5014488-5014488 | p.H222H | 1 |
Top |
![]() |
|
![]() |
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample |   | 3 | 1 |   | 1 |   |   |   | 3 |   |   | 2 |   | 4 |   | 1 | 3 | 4 |   | 6 |
# mutation |   | 3 | 1 |   | 1 |   |   |   | 3 |   |   | 2 |   | 4 |   | 1 | 4 | 4 |   | 6 |
nonsynonymous SNV |   | 3 | 1 |   | 1 |   |   |   | 2 |   |   | 1 |   | 3 |   |   | 2 | 3 |   | 5 |
synonymous SNV |   |   |   |   |   |   |   |   | 1 |   |   | 1 |   | 1 |   | 1 | 2 | 1 |   | 1 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
![]() |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr10:5014844 | p.R250Q | 2 |
chr10:5014864 | p.L94V | 1 |
chr10:5008137 | p.D109D | 1 |
chr10:5011056 | p.L257L | 1 |
chr10:5014882 | p.V128M | 1 |
chr10:5008151 | p.R263C | 1 |
chr10:5011059 | p.E274K | 1 |
chr10:5014915 | p.A150A | 1 |
chr10:5008166 | p.R278T | 1 |
chr10:5011070 | p.V151M | 1 |
![]() |
![]() |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
![]() |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for AKR1C1 |
![]() |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
![]() |
![]() |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
![]() |
Top |
![]() |
* This plots show the correlation between CNV and gene expression. |
![]() | |
![]() |
Top |
Gene-Gene Network Information |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
![]() | |||||
ADH7,AKR1B10,AKR1C1,AKR1C2,AKR1C3,ALDH3A1,FOXE1, GAGE2B,GPX2,IL36A,IQCF2,KRT13,LOC285629,NAPSA, RBMXL2,SFTPA1,SFTPB,TMPRSS11B,UGT1A5,VCX,VCX3A | AIFM2,AKR1C1,AKR1C2,AKR1C3,ANXA5,BHMT2,BTD, CAV1,DHDDS,EPHX1,GCOM1,GLYAT,ITGB1BP1,ITIH5, ITPK1,MCAM,PALMD,SPARC,TK2,TMEM37,VKORC1L1 | ||||
![]() | |||||
AKR1C1,AKR1C2,AKR1C3,AKR1C4,BEX5,BST1,CDH12, CST1,DEFB104A,ENPP2,HAO2,LRRC69,N6AMT2,OR10X1, OR13H1,S100Z,SLC12A1,SLC28A1,TEKT3,UGT1A9,UNC5D | AKR1C1,ARPP21,NYAP1,CELF6,CNTN5,CPLX2,CRIPAK, DDX25,EGFL8,GAL,HCN1,HMP19,JPH3,LOC157627, MYT1,NDRG4,PTPRN,RPH3A,RSPO4,STMN4,TTC9B |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
![]() |
Top |
Pharmacological Information for AKR1C1 |
![]() |
DB Category | DB Name | DB's ID and Url link |
![]() |
* Gene Centered Interaction Network. |
![]() |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00157 | aldo-keto reductase family 1, member C1 | approved; nutraceutical | NADH | ![]() | ![]() |
DB00936 | aldo-keto reductase family 1, member C1 | approved | Salicyclic acid | ![]() | ![]() |
DB00945 | aldo-keto reductase family 1, member C1 | approved | Acetylsalicylic acid | ![]() | ![]() |
DB03461 | aldo-keto reductase family 1, member C1 | experimental | 2'-Monophosphoadenosine 5'-Diphosphoribose | ![]() | ![]() |
DB04674 | aldo-keto reductase family 1, member C1 | experimental | 2-HYDROXY-3,5-DIIODOBENZOIC ACID | ![]() | ![]() |
DB07768 | aldo-keto reductase family 1, member C1 | experimental | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | ![]() | ![]() |
DB07931 | aldo-keto reductase family 1, member C1 | experimental | 4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol | ![]() | ![]() |
Top |
Cross referenced IDs for AKR1C1 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |